Elena Moro (EM): As incoming co-chair of the Scientific Panel “Neuro-oncology” can you briefly introduce yourself and your specific field of expertise to the Neuropenews readers. Stefan Oberndorfer (SO): As a Neurologist, my special field of interest is clinical Neuro-oncology. Presently, I am working as a head of Department for Neurology at the Karl Landsteiner University Clinic of St Pölten in Austria. My main areas of clinical research are brain tumors, tumor associated epilepsy, palliative care in brain tumor patients, spinal metastases, neurotoxicity of anticancer treatment, paraneoplastic neurological syndromes and symptomatic treatment in neuro-oncology.

Dear Readers, We invite you to read the following article recommendations, prepared for you by our Scientific Panels: Dementia and cognitive disorders, Higher cortical functions, Infectious diseases, Movement disorders, Palliative care. Winblad B, Amouyel P, Andrieu S, et al. Defeating… Continue Reading

or April 2016 we have selected: Lublin F, Miller DH, Freedman MS, et al., on behalf of the INFORMS study investigators. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomized, double-blind, placebo-controlled trial. Lancet Neurol, 27 Jan 2016; pii: S0140-6736(15)01314-8. doi: 10.1016/S0140-6736(15)01314-8. Primary progressive multiple sclerosis (PPMS) represents around 10-15% of the clinical forms of MS. Several characteristics differentiate PPMS from the relapse-onset MS, the classical more frequent form: older age at onset, equal prevalence between sexes, less inflammatory component at the MRI, and quicker progression of disability.

Pain - the unpleasant sensory and emotional experience associated with tissue damage - is usually not considered to be a neurological sub-disciplines like for example cerebrovascular diseases, demyelinating disorders, neururomuscular diseases, movement disorders, epilepsy, headache and clinical neurophysiology.

As in the previous years, EAN-RRFS delegate will join the EAN Spring School 2016 and the Regional Teaching courses (RTC) in order to spread information regarding postgraduate education in neurology and relevant opportunities for neurologists in training. This year, our representatives providing the updated information will be Panagiotis Zis (EAN Spring School 2016, May 12-15, 2016 Stare Splavy, Czech Republic), Orsolya Gyorfi (RTC, Kutasi, Georgia, Oct. 6-8, 2016), and Viktoria Papp (RTC, Yekaterinburg, Russia, Nov. 3-5, 2016).

All associate individual members of the 47 neurological societies that belong to the EAN are eligible to receive FREE online access to European Journal of Neurology (the official journal of the EAN).

In February 2016 the new Quality Management System (QMS) of the EAN Admin has been reviewed by an external auditor from the Quality Austria. Eveline Sipido from Brussels and Magda Dohnalová from Prague also participated in this audit at the EAN Head Office in Vienna.

Many European Neurologists are aware of Neuropenews, the blog/newsletter of the European Academy of Neurology (EAN). Neuropenews is a platform free to all EAN members.

by Anna Sauerbier   After a stroke, electric stimulation can boost recovery ExoMars European-Russian probe lifts off to search for life on the red planet How to enhance the value Europe gets from its healthcare expenditure Advanced implant that would… Continue Reading

At the Board meeting of the European Brain Council that took place in Brussels on February 18th, a new Executive was elected.
Prof. Wolfgang Oertel, coordinator of the EAsC – European Affairs sub-Committee of the EAN was elected Treasurer to… Continue Reading

Together Under the Umbrella for Huntington’s Disease A Public Awareness Day for: Patients, Carers, Families and Health Professionals When: Saturday, 28 May 2016 – 10.30am – 5.00pm
Where: DGI-byen, Tietgensgade 65 1704 Copenhagen V, Denmark As part of the “Together… Continue Reading